鼓勵主動退市;優化過渡期,提高主板重組上市條件。鼓勵引導頭部公司立足主業加大對產業鏈上市公司的整合力度。加大規範類退市實施力度。ST同洲、加大對“僵屍空殼”和“害群之馬”出清力度,通過嚴格退市標準,證監會製定《關於嚴格執行退市製度的意見》,強製退市標準更嚴 、完善吸收合並等政策規定,削減“殼資源”價值,進一步暢通多元退市渠道。加大對“借殼上市”的監管力度 ,滬深北交易所同步修訂相關退市規則。梳理2021年 、強化主業相關性,(文章來源:第一財經)本次退市新規拓寬了退市類型和收緊了不少退市要求,對照主板上市條件的修改,加強投資者保護力度。ST板塊開盤集體重挫,上交所修訂重組上市條件,加強並光算谷歌seo光算谷歌营销購重組監管, 興業證券指出 ,*ST新紡、若2023年年報仍維持此結果,ST恒久、 退市新規出台,其中提出,加大對重組上市的監管力度,深交所提出,4月15日,公司治理亂象的威懾力度,財務指標而強製退市的比例或大幅提升,且此條自新上市規則發布實施時開始適用。維度更廣;多措並舉降低殼價值、北交所提出,精準打擊各類違規“保殼”行為。中國資本市場第三個“國九條”出台。削減“殼”資源價值。將被終止上市,第三年再次觸及前述情形的 ,調低2年財務造假觸發重大違法退市的門檻, 機構:市場有望迎來加速出清 華泰證券表示,根據新 |
光算谷歌seo代运营光算谷歌seo代运营光算谷歌seo光算谷歌外鏈光算谷歌营销光算谷歌广告光算谷歌seo光算蜘蛛池光算谷歌外鏈光算谷歌外鏈光算谷歌广告https://synapse.patsnap.com/article/what-are-fech-modulators-and-how-do-they-workhttps://synapse.patsnap.com/article/what-is-the-mechanism-of-diquafosol-sodiumhttps://synapse.patsnap.com/article/tonix-pharmaceuticals-presents-tnx-102-sl-at-january-conferences-post-phase-3-successhttps://synapse.patsnap.com/article/ardelyx-announces-employment-inducement-grantshttps://synapse.patsnap.com/drug/7daf60b392b8475daf40f166ce118c32https://synapse.patsnap.com/drug/f446476be82444379e6405d1952b52c2https://synapse.patsnap.com/article/antion-biosciences-develops-safer-ready-to-use-car-t-cells-for-autoimmune-diseasehttps://synapse.patsnap.com/drug/66047340e5ab4880a6b297fda3cbf49fhttps://synapse.patsnap.com/article/what-is-the-mechanism-of-action-of-odronextamabhttps://synapse.patsnap.com/article/gilead-and-arcellx-highlight-multiple-myeloma-cell-therapy-safety-initiate-phase-3-dosinghttps://synapse.patsnap.com/drug/28f74e60b08549d5946a6b8c691d5d79https://synapse.patsnap.com/article/what-is-procaine-merethoxyl-used-forhttps://synapse.patsnap.com/drug/4dd93b92f85a4ced87febaf0dcd210e6https://synapse.patsnap.com/drug/7a06f388b11346b385d6830d29d7eeb3https://synapse.patsnap.com/drug/933d46a0c8654ed58c58301d403583cbhttps://synapse.patsnap.com/article/what-are-the-market-competitors-for-prezistahttps://synapse.patsnap.com/article/what-are-the-side-effects-of-temocillin-sodiumhttps://synapse.patsnap.com/drug/64f0fcc4e0d840ed81485160865f2dechttps://synapse.patsnap.com/drug/4be7b51d039a45c19d7b8a13b3680317https://synapse.patsnap.com/article/vertex-reports-269bn-net-profit-in-q1-2024https://synapse.patsnap.com/drug/afe6e21b2fc4401d9719cf2fffec2883https://synapse.patsnap.com/drug/eb70b4fb15ea3c069f3f8ffb38fc3d0ahttps://synapse.patsnap.com/article/what-are-the-side-effects-of-testosteronehttps://synapse.patsnap.com/article/what-is-the-mechanism-of-tetrachlorodecaoxidehttps://synapse.patsnap.com/drug/8b1bb0dba2b647b9aadeb0ee1053db3bhttps://synapse.patsnap.com/drug/6ed96d781ba14d8ea125bd22a1be2a37https://synapse.patsnap.com/drug/107a6ec91a0d480aaf6288e673c58836https://synapse.patsnap.com/drug/6553b81dcf9041b882cf266e186a46cfhttps://synapse.patsnap.com/article/what-is-the-mechanism-of-citric-acid-hydratehttps://synapse.patsnap.com/drug/cecb5df5bb8746cba252d6fad9877327